Clinical Supply Agreement Template for Singapore

A Clinical Supply Agreement is a specialized contract that governs the supply of investigational products, medical devices, and related materials for clinical trials in Singapore. This agreement establishes clear obligations between suppliers, sponsors, and clinical sites while ensuring compliance with Singapore's comprehensive regulatory framework governing clinical research.

When do you need this document?

You need a Clinical Supply Agreement when conducting any clinical trial in Singapore that involves the supply of investigational products or medical devices. This includes Phase I through Phase IV trials, bioequivalence studies, and post-marketing surveillance studies. The agreement is essential when working with third-party manufacturers, contract research organizations (CROs), or when establishing supply relationships between sponsors and clinical sites. You'll also require this document when importing clinical trial materials into Singapore or when local manufacturing is involved in the study supply chain.

Key legal considerations

The agreement must clearly define quality requirements, including Good Manufacturing Practice (GMP) compliance and product specifications that meet HSA standards. Supply obligations should specify quantities, delivery timelines, storage conditions, and handling requirements for investigational products. Include provisions for product recall procedures, adverse event reporting, and chain of custody documentation. The contract should address intellectual property rights, confidentiality obligations, and liability allocation between parties. Temperature monitoring, batch record requirements, and certificate of analysis provisions are critical for regulatory compliance. Consider including force majeure clauses and backup supply arrangements to ensure continuity of clinical trials.

Legal requirements in Singapore

Under the Medicines Act and Health Products Act, all clinical trial supplies must comply with HSA's regulatory requirements and Good Manufacturing Practice standards. The supplier must hold appropriate manufacturing licenses and import permits as required by Singapore's regulatory framework. The agreement must ensure compliance with the Medicines (Clinical Trials) Regulations and Health Products (Clinical Trials) Regulations, including proper labeling, packaging, and documentation requirements. All parties must adhere to Singapore's Good Clinical Practice guidelines and maintain proper records for HSA inspections. The contract should reference the Human Biomedical Research Act requirements for ethical approval and participant protection. Supply chain integrity must be maintained through proper documentation, and any changes to manufacturing or specifications require HSA notification as mandated by Singapore's clinical trial regulations.